Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter Veterinary Remove Veterinary filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Paediatric investigation plans Remove Paediatric investigation plans filter Orphan designations Remove Orphan designations filter Direct healthcare professional communication Remove Direct healthcare professional communication filter Summaries of opinion (23) Apply Summaries of opinion filter Withdrawn applications (39) Apply Withdrawn applications filter Referrals (17) Apply Referrals filter

Product number

Patient safety

Yes (10) Apply Yes filter

Authorisation status

Authorised (666) Apply Authorised filter Refused (4) Apply Refused filter Withdrawn (118) Apply Withdrawn filter

ATC code

Species

Marketing authorisation date

From:

To:

Marketing authorisation holder

Pharmacotherapeutic group

Date of opinion

From:

To:

PIP decision type

P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s) (18) Apply P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s) filter PM: decision on the application for modification of an agreed PIP (170) Apply PM: decision on the application for modification of an agreed PIP filter RPM: decision refers to a refusal on the application for modification of an agreed PIP (2) Apply RPM: decision refers to a refusal on the application for modification of an agreed PIP filter RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s) (1) Apply RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s) filter W: decision granting a waiver in all age groups for all conditions or indications (38) Apply W: decision granting a waiver in all age groups for all conditions or indications filter

PIP condition / indication

Pharmaceutical form(s)

Route(s) of administration

Decision date

From:

To:

PIP compliance check

Yes (24) Apply Yes filter

Compliance procedure number

Orphan designation – intended use

Orphan decision number

Orphan designation status

Positive (132) Apply Positive filter Withdrawn (1) Apply Withdrawn filter

Medicine type

Accelerated assessment Remove Accelerated assessment filter Additional monitoring Remove Additional monitoring filter Biosimilar Remove Biosimilar filter Generic Remove Generic filter Conditional approval (118) Apply Conditional approval filter Exceptional circumstances (88) Apply Exceptional circumstances filter Orphan medicine (526) Apply Orphan medicine filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

1189 results

Remove all filtersRemove all filters

Medicine type Accelerated assessment Remove Accelerated assessment filter Generic Remove Generic filter Biosimilar Remove Biosimilar filter Additional monitoring Remove Additional monitoring filter

Medicine Orphan designations Remove Orphan designations filter Paediatric investigation plans Remove Paediatric investigation plans filter European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Direct healthcare professional communication Remove Direct healthcare professional communication filter

Categories Veterinary Remove Veterinary filter Human Remove Human filter

Sort by

List item

Human medicine European public assessment report (EPAR): Kaftrio (updated)

ivacaftor, tezacaftor, elexacaftor, Cystic Fibrosis
Date of authorisation: 21/08/2020, , , Revision: 12, Authorised, Last updated: 07/06/2023
List item

Human medicine European public assessment report (EPAR): Atazanavir Krka (updated)

atazanavir (as sulfate), HIV Infections
Date of authorisation: 25/03/2019, , Revision: 2, Authorised, Last updated: 07/06/2023
List item

Human medicine European public assessment report (EPAR): Ibrance (updated)

Palbociclib, Breast Neoplasms
Date of authorisation: 09/11/2016, , Revision: 16, Authorised, Last updated: 06/06/2023
List item

Human medicine European public assessment report (EPAR): Tezspire (updated)

tezepelumab, Asthma
Date of authorisation: 19/09/2022, , Revision: 4, Authorised, Last updated: 05/06/2023
List item

Human medicine European public assessment report (EPAR): Vydura (updated)

Rimegepant, Migraine Disorders
Date of authorisation: 25/04/2022, , Revision: 5, Authorised, Last updated: 05/06/2023
List item

Human medicine European public assessment report (EPAR): Xerava (updated)

eravacycline, Infection; Bacterial Infections
Date of authorisation: 20/09/2018, , Revision: 7, Authorised, Last updated: 05/06/2023
List item

Human medicine European public assessment report (EPAR): Lacosamide Adroiq (updated)

lacosamide, Epilepsy
Date of authorisation: 31/05/2023, , Authorised, Last updated: 05/06/2023
List item

Human medicine European public assessment report (EPAR): Onpattro (updated)

patisiran sodium, Amyloidosis, Familial
Date of authorisation: 27/08/2018, , , , Revision: 11, Authorised, Last updated: 02/06/2023
List item

Human medicine European public assessment report (EPAR): Adynovi (updated)

rurioctocog alfa pegol, Hemophilia A
Date of authorisation: 08/01/2018, , Revision: 9, Authorised, Last updated: 02/06/2023
List item

Human medicine European public assessment report (EPAR): Rinvoq (updated)

upadacitinib, Arthritis, Rheumatoid
Date of authorisation: 16/12/2019, , , Revision: 15, Authorised, Last updated: 02/06/2023
List item

Human medicine European public assessment report (EPAR): Oxervate (updated)

Recombinant human nerve growth factor, Keratitis
Date of authorisation: 06/07/2017, , , , Revision: 2, Authorised, Last updated: 02/06/2023
List item

Human medicine European public assessment report (EPAR): Zoledronic acid Actavis (updated)

zoledronic acid monohydrate, Fractures, Bone
Date of authorisation: 20/04/2012, , Revision: 15, Authorised, Last updated: 01/06/2023
List item

Human medicine European public assessment report (EPAR): Telmisartan Actavis (updated)

Telmisartan, Hypertension
Date of authorisation: 29/09/2010, , Revision: 12, Authorised, Last updated: 01/06/2023
List item

Human medicine European public assessment report (EPAR): Tadalafil Mylan (updated)

tadalafil, Erectile Dysfunction
Date of authorisation: 21/11/2014, , Revision: 15, Authorised, Last updated: 01/06/2023
List item

Human medicine European public assessment report (EPAR): Actelsar HCT (updated)

Telmisartan, hydrochlorothiazide, Essential Hypertension
Date of authorisation: 13/03/2013, , Revision: 15, Authorised, Last updated: 01/06/2023
List item

Human medicine European public assessment report (EPAR): Levetiracetam Actavis Group (updated)

levetiracetam, Epilepsy
Date of authorisation: 04/12/2011, , Revision: 17, Authorised, Last updated: 01/06/2023
List item

Human medicine European public assessment report (EPAR): Desloratadine Actavis (updated)

desloratadine, Rhinitis, Allergic, Perennial; Urticaria; Rhinitis, Allergic, Seasonal
Date of authorisation: 13/01/2012, , Revision: 16, Authorised, Last updated: 01/06/2023
List item

Human medicine European public assessment report (EPAR): Vildagliptin / Metformin hydrochloride Accord (updated)

metformin hydrochloride, vildagliptin, Diabetes Mellitus, Type 2
Date of authorisation: 24/03/2022, , , Revision: 2, Authorised, Last updated: 01/06/2023
List item

Human medicine European public assessment report (EPAR): Empliciti (updated)

Elotuzumab, Multiple Myeloma
Date of authorisation: 11/05/2016, , Revision: 12, Authorised, Last updated: 01/06/2023
List item

Human medicine European public assessment report (EPAR): Pioglitazone Actavis (updated)

pioglitazone hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 15/03/2012, , Revision: 9, Authorised, Last updated: 01/06/2023
List item

Human medicine European public assessment report (EPAR): Ebilfumin (updated)

oseltamivir, Influenza, Human
Date of authorisation: 22/05/2014, , Revision: 15, Authorised, Last updated: 01/06/2023
List item

Human medicine European public assessment report (EPAR): Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva (updated)

efavirenz, emtricitabine, tenofovir disoproxil phosphate, HIV Infections
Date of authorisation: 17/07/2017, , Revision: 10, Authorised, Last updated: 01/06/2023
List item

Human medicine European public assessment report (EPAR): Benepali (updated)

etanercept, Arthritis, Psoriatic; Arthritis, Rheumatoid; Psoriasis
Date of authorisation: 13/01/2016, , Revision: 20, Authorised, Last updated: 01/06/2023
List item

Human medicine European public assessment report (EPAR): Sildenafil Actavis (updated)

sildenafil, Erectile Dysfunction
Date of authorisation: 10/12/2009, , Revision: 16, Authorised, Last updated: 01/06/2023
List item

Human medicine European public assessment report (EPAR): Potactasol (updated)

topotecan, Uterine Cervical Neoplasms; Small Cell Lung Carcinoma
Date of authorisation: 06/01/2011, , Revision: 11, Authorised, Last updated: 01/06/2023

Load more

1189 results

Human medicine European public assessment report (EPAR): Kaftrio (updated)

Human medicine European public assessment report (EPAR): Atazanavir Krka (updated)

Human medicine European public assessment report (EPAR): Ibrance (updated)

Human medicine European public assessment report (EPAR): Tezspire (updated)

Human medicine European public assessment report (EPAR): Vydura (updated)

Human medicine European public assessment report (EPAR): Xerava (updated)

Human medicine European public assessment report (EPAR): Lacosamide Adroiq (updated)

Human medicine European public assessment report (EPAR): Onpattro (updated)

Human medicine European public assessment report (EPAR): Adynovi (updated)

Human medicine European public assessment report (EPAR): Rinvoq (updated)

Human medicine European public assessment report (EPAR): Oxervate (updated)

Human medicine European public assessment report (EPAR): Zoledronic acid Actavis (updated)

Human medicine European public assessment report (EPAR): Telmisartan Actavis (updated)

Human medicine European public assessment report (EPAR): Tadalafil Mylan (updated)

Human medicine European public assessment report (EPAR): Actelsar HCT (updated)

Human medicine European public assessment report (EPAR): Levetiracetam Actavis Group (updated)

Human medicine European public assessment report (EPAR): Desloratadine Actavis (updated)

Human medicine European public assessment report (EPAR): Vildagliptin / Metformin hydrochloride Accord (updated)

Human medicine European public assessment report (EPAR): Empliciti (updated)

Human medicine European public assessment report (EPAR): Pioglitazone Actavis (updated)

Human medicine European public assessment report (EPAR): Ebilfumin (updated)

Human medicine European public assessment report (EPAR): Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva (updated)

Human medicine European public assessment report (EPAR): Benepali (updated)

Human medicine European public assessment report (EPAR): Sildenafil Actavis (updated)

Human medicine European public assessment report (EPAR): Potactasol (updated)